comparemela.com

Page 6 - Ophthalmic Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bausch + Lomb Co (NYSE:BLCO) Sees Significant Drop in Short Interest

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) saw a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 3,440,000 shares, a drop of 10.4% from the November 15th total of 3,840,000 shares. Based on an average daily volume of 429,000 shares, the days-to-cover […]

Bausch + Lomb (NYSE:BLCO) Sees Large Volume Increase

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) saw strong trading volume on Wednesday . 743,354 shares traded hands during mid-day trading, an increase of 73% from the previous session’s volume of 430,503 shares.The stock last traded at $15.04 and had previously closed at $14.89. Wall Street Analysts Forecast Growth Several equities analysts recently […]

Alamar Capital Management LLC Has $2 19 Million Stock Position in Bausch + Lomb Co (NYSE:BLCO)

Alamar Capital Management LLC raised its holdings in Bausch + Lomb Co. (NYSE:BLCO – Free Report) by 2.0% during the second quarter, HoldingsChannel reports. The firm owned 109,235 shares of the company’s stock after acquiring an additional 2,159 shares during the quarter. Bausch + Lomb accounts for 1.6% of Alamar Capital Management LLC’s holdings, making […]

Bausch + Lomb Co (NYSE:BLCO) Short Interest Update

Bausch + Lomb Co (NYSE:BLCO) Short Interest Update
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Bausch + Lomb (NYSE:BLCO) Given New $18 50 Price Target at Morgan Stanley

Bausch + Lomb (NYSE:BLCO – Get Free Report) had its price target dropped by equities researchers at Morgan Stanley from $20.00 to $18.50 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an “equal weight” rating on the stock. Morgan Stanley’s price objective would suggest a potential upside of 12.87% […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.